Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("piribedil")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 227

  • Page / 10
Export

Selection :

  • and

Chemically modified carbon paste electrode for the potentiometric flow injection analysis of piribedil in pharmaceutical preparation and urineIBRAHIM, Hosny.Journal of pharmaceutical and biomedical analysis. 2005, Vol 38, Num 4, pp 624-632, issn 0731-7085, 9 p.Article

Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairmentNAGARAJA, Dindagur; JAYASHREE, Sivaramakrishnan.The American journal of psychiatry. 2001, Vol 158, Num 9, pp 1517-1519, issn 0002-953XArticle

Early piribedil monotherapy of Parkinson's disease : A planned seven-month report of the REGAIN studyRASCOL, Olivier; DUBOIS, Bruno; CALDAS, Alexandre Castro et al.Movement disorders. 2006, Vol 21, Num 12, pp 2110-2115, issn 0885-3185, 6 p.Article

Enhancement in dissolution pattern of piribedil by molecular encapsulation with β-cyclodextrinDEMIREL, M; BÜYÜKKÖROGLU, G; KALAVA, B. S et al.Methods and findings in experimental and clinical pharmacology. 2006, Vol 28, Num 2, pp 83-88, issn 0379-0355, 6 p.Article

Electroanalytical characteristics of piribedil and its differential pulse and square wave voltammetric determination in pharmaceuticals and human serumUSLU, Bengi; ÖZKAN, Sibel A.Journal of pharmaceutical and biomedical analysis. 2003, Vol 31, Num 3, pp 481-489, issn 0731-7085, 9 p.Article

Effects of the dopamine agonist piribedil on prefrontal temporal cortical network function in normal aging as assessed by verbal fluencyGIERSKI, Fabien; PERETTI, Charles-Siegfried; ERGIS, Anne-Marie et al.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 1, pp 262-268, issn 0278-5846, 7 p.Article

The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's diseaseCASTRO-CALDAS, Alexandre; DELWAIDE, Paul; JOST, Wolfgang et al.Movement disorders. 2006, Vol 21, Num 4, pp 500-509, issn 0885-3185, 10 p.Article

Piribédil: attaques de sommeil, chez des patients non parkinsoniens aussiLa Revue Prescrire. 2013, Vol 33, Num 355, issn 0247-7750, p. 351Article

Piribedil for restless legs syndrome: A pilot studyEVIDENTE, Virgilio Gerald H.Movement disorders. 2001, Vol 16, Num 3, pp 579-581, issn 0885-3185Article

STUDIO TERMOGRAFICO DELLE VARIAZIONI DI APPORTO SANGUIGNO NEL DISTRETTO CAROTIDO-OFTALMICO IN SOGGETTI TRATTATI CON PIRIBEDIL = ETUDE THERMOGRAPHIQUE DES VARIATIONS DE L'APPORT SANGUIN DANS LE TERRITOIRE CAROTIDO-OPHTALMIQUE CHEZ LES SUJETS TRAITES PAR LE PIRIBEDILGHISOLFI A; TAFI A.1976; MINERVA MED.; ITAL.; DA. 1976; VOL. 67; NO 26; PP. 1681-1688; BIBL. 14 REF.Article

ET495 AND BRAIN CATECHOLAMINE MECHANISMS: EVIDENCE FOR STIMULATION OF DOPAMINE RECEPTORS = ET495 ET MECANISMES DES CATECHOLAMINES CEREBRALES: MISE EN EVIDENCE DE LA STIMULATION DES RECEPTEURS DOPAMINERGIQUESCORRODI H; FARNEBO LO; FUXE K et al.1972; EUROP. J. PHARMACOL.; NETHERL.; DA. 1972; VOL. 20; NO 2; PP. 195-204; BIBL. 1P.1/2Serial Issue

Orodispersible Sublingual Piribedil to Abort OFF Episodes: A Single Dose Placebo-Controlled, Randomized, Double-Blind, Cross-Over StudyRASCOL, Olivier; AZULAY, Jean-Philippe; GROUIN, Jean-Marie et al.Movement disorders. 2010, Vol 25, Num 3, pp 368-376, issn 0885-3185, 9 p.Article

Piribedil-selective electrodes based on Bi(III)-iodide and Hg(II)-iodide complexesABDEL-GAWAD, Fatama M; ISSA, Yousry M; HASSOUNA, Mohamed E. M et al.Mikrochimica acta (1966. Print). 2003, Vol 141, Num 1-2, pp 7-13, issn 0026-3672, 7 p.Article

Récepteurs α2-adrénergiques et maladie de Parkinson = α2-adrenergic receptors and Parkinson's diseaseBONNET, Anne-Marie.La Presse médicale (1983). 2002, Vol 31, Num 25, pp 1193-1195, issn 0755-4982Article

ACTION DE DIVERS REACTIFS PHARMACOLOGIQUES SUR LES MOUVEMENTS STEREOTYPES PRODUITS CHEZ LE RAT PAR L'INJECTION DE 1-(2PYRIMIDYL)-4 PIPERONYL PIPERAZINE (PIRIBEDIL)POIGNANT JC; LAUBIE M; TSOUCARIS KUPFER D et al.1972; C. R. ACAD. SCI., D; FR.; DA. 1972; VOL. 275; NO 5; PP. 715-717; BIBL. 7REF.Serial Issue

INTERET DU PIRIBEDIL DANS LE TRAITEMENT DES VASCULOPATHIES RETINIENNES DEGENERATIVESPERDRIEL G; CHEVALERAUD JP; DECROIX G et al.1974; BULL. SOC. OPHTALMOL. FR.; FR.; DA. 1974; VOL. 74; NO 4; PP. 445-448Article

Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover studyTAN, E. K; RATNAGOPAL, P; HAN, S. Y et al.Acta neurologica scandinavica. 2003, Vol 107, Num 3, pp 202-206, issn 0001-6314, 5 p.Article

Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedilTHOBOIS, Stéphane; LHOMMEE, Eugénie; PELISSIER, Pierre et al.Brain. 2013, Vol 136, pp 1568-1577, issn 0006-8950, 10 p., 5Article

Quantitative determination of some pharmaceutical piperazine derivatives through complexation with iron(III) chlorideABOU-ATTIA, F. M; ISSA, Y. M; ABDEL-GAWAD, F. M et al.Il Farmaco (Pavia). 2003, Vol 58, Num 8, pp 573-579, issn 0014-827X, 7 p.Article

Activité du piribédil dans la maladie de Parkinson : Etude multicentrique = Activity of piridebil in Parkinson's disease : a multicenter studyZIEGLER, M; RONDOT, P.La Presse médicale (1983). 1999, Vol 28, Num 26, pp 1414-1418, issn 0755-4982Article

REFLEXIONS SUR LE TRAITEMENT DES MYOPATHIES DEGENERATIVES PAR UNE MEDICATION VASO-ACTIVE (PIRIBECIL)SCHMITT J; SCHMIDT C; ROYER R et al.1976; ANN. MED. NANCY; FR.; DA. 1976; VOL. 15; PP. 263-264; BIBL. 2 REF.Article

Parkinsonism-drig treatment. IIBERG, M. J; EBERT, B; WILLIS, D. K et al.Drug intelligence & clinical pharmacy. 1987, Vol 21, Num 2, pp 167-172, issn 0012-6578Article

RAPPORTO SULL'IMPIEGO DEL PIRIBEDIL NELLE AFFEZIONI VASCOLARI ED EMORRAGICHE DEL POLO POSTERIORE DELL'OCCHIO = ETUDE DE L'UTILISATION DU PIRIBEDIL DANS LES AFFECTIONS VASCULAIRES ET HEMORRAGIQUES DU POLE POSTERIEUR DE L'OEILDE MOLFETTA; LAURI G.1976; MINERVA MED.; ITAL.; DA. 1976; VOL. 67; NO 26; PP. 1696-1697Article

End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients : A pharmacokinetic/pharmacodynamic, randomized, double-blind studySIMON, Nicolas; MICALLEF, Joëlle; REYNIER, Jean-Charles et al.Movement disorders. 2005, Vol 20, Num 7, pp 803-809, issn 0885-3185, 7 p.Article

Piribedil-induced sleep attacks in Parkinson's diseaseTAN, E. K.Fundamental & clinical pharmacology. 2003, Vol 17, Num 1, pp 117-119, issn 0767-3981, 3 p.Article

  • Page / 10